Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Accelerating Spirocyclic Polyketide Synthesis
Powerful flow chemistry techniques used for complex multi-stage synthesis of spirocyclic polyketides.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
First Atlas of Body Clock Gene Expression in Mammals Informs Timing of Drug Delivery
Penn Medicine study has implications for 100 top-selling US drugs, half of which target daily-oscillating genes.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Blood Test Developed to Diagnose Early Onset Alzheimer’s Disease
New blood-test could predict a person’s risk of developing AD much earlier than is currently possible.
Tea and Citrus Products Could Lower Ovarian Cancer Risk
New UEA research finds that women who consume foods containing flavonols and flavanones significantly decrease their risk of developing epithelial ovarian cancer.
TxCell Achieves Positive Results for Col-Treg in a Model of Autoimmune Uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic candidate in this rare eye disease.
Heart Drug May Help Treat ALS, Mouse Study Shows
Scientists blocked the enzyme in ALS astrocytes using digoxin, a medication used in the treatment of heart failure.
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.
LLNL, UC Davis Partner to Personalize Cancer Medications
With a $7.8 million, five-year grant from the NIH researchers are utilizing accelerator mass spectrometry for cancer research.
Scroll Up
Scroll Down
Return
Next Generation X-Aptamers for Identification of Personalized Biomarkers in Cancer
David G. Gorenstein, Ph.D., University of Texas Health Sciences Center, speaking at Genomics Research 2012.
Date Posted: Monday, January 07, 2013
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Researchers Reveal Genomic Diversity Of Individual Lung Tumors
Findings suggest sequencing a single region of a localized tumor will identify driver mutations.
Friday, October 10, 2014
How Fluid Flow Influences Neuron Growth
A University of Texas at Arlington team exploring how neuron growth can be controlled in the lab and, possibly, in the human body has published a new paper in Nature Scientific Reports on how fluid flow could play a significant role.
Wednesday, October 08, 2014
Method Developed at UT Arlington Allows Quantitative Nanoscopic Imaging Through Silicon
A team of scientists has figured out how to quantitatively observe cellular processes taking place on so-called “lab on a chip” devices in a silicon environment.
Monday, October 07, 2013
Chlamydia Protein has an Odd Structure
Research could lead to new ways to combat this sexually transmitted disease.
Thursday, June 13, 2013
Researchers Reveal New Enzyme that Acts as Innate Immunity Sensor
Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections.
Monday, February 18, 2013
Unique Peptide Could Treat Cancers, Neurological Disorders, Infectious Diseases
Scientists have synthesized a peptide that shows potential for pharmaceutical development through an ability to induce a cell-recycling process called autophagy.
Monday, February 18, 2013
Designer Bacteria May Lead to Better Vaccines
Researchers have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
Wednesday, January 23, 2013
Biologists Unlocking the Secrets of Plant Defenses, One Piece at a Time
Researchers examining how the hormone jasmonate works to protect plants and promote their growth have revealed how a transcriptional repressor of the jasmonate signaling pathway makes its way into the nucleus of the plant cell.
Thursday, December 13, 2012
Metabolic Protein Launches Sugar Feast that Nurtures Brain Tumors
PKM2 slips into nucleus to promote cancer; potential biomarker and drug approach discovered.
Wednesday, November 28, 2012
Ancient Enzymes Function like Nanopistons to Unwind RNA
Molecular biologists have solved one of the mysteries of how double-stranded RNA is remodeled inside cells in both their normal and disease states.
Wednesday, September 05, 2012
Seed Size is Controlled by Maternally Produced Small RNAs, Scientists Find
Seed size is controlled by maternally produced small RNAs, scientists find.
Thursday, April 12, 2012
Good Cholesterol' Nanoparticles Seek and Destroy Cancer Cells
Nanoparticles loaded with small interfering RNA to silence cancer-promoting genes selectively shrunk or destroyed ovarian cancer tumors in mice.
Thursday, May 05, 2011
'Good Cholesterol' Nanoparticles Seek and Destroy Cancer Cells
Scientists package HDL with gene-silencing siRNA to target tumors, spare normal tissue.
Wednesday, April 13, 2011
UT Houston Researchers Launch Phase II Trial Of Stem Cells And Acute Heart Attack
Phase I results show mesenchymal stem cells safe, may help repair heart.
Tuesday, December 15, 2009
M. D. Anderson Study Questions True Favorability of Rare Breast Cancer Type
In an era of minimalist therapy, some mucinous carcinoma patients may need more, not less, treatment.
Monday, December 14, 2009
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv